Impact of the addition of bevacizumab, oxaliplatin, or irinotecan to fluoropyrimidin in the first-line treatment of metastatic colorectal cancer in elderly patients

International Journal of Colorectal Disease

from Gastroenterology via xlomafota13 on Inoreader https://ift.tt/2Lzk2he
via IFTTT